Skip to main content
. 2021 Aug 23;78(3):294–302. doi: 10.3105310.31053/1853.0605.v78.n3.32800

Table N° 3. ICU patients results.

  Ruxolitinib group SoC group P
(n = 19) (n = 17)
High flow cannula needing 6 3 NS (*)
N (%) (31.6%) (17.6%)
Mechanical ventilation 13 14 NS
(68.4%) 82.3% (*)
Hospitalization duration before ICU, days (median, range) 4 5 NS
(1-17) (0-14) (**)
Hospitalization in ICU, days (median, range) 7 8 NS
(2-41) (0-37) (**)
Deaths (n, %) 0 (0%) 5 (29.4%) 0.05 (*)

(*) Fisher exact test

(**) U Mann-Whitney test